Citation Tools
Abstracts Accepted for Publication
Spondyloarthritis - treatment
AB0696 Retention rates of adalimumab, etanercept, and infliximab as first- or second-line biotherapies for spondyloarthritis patients in daily practice in auvergne (france)
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- AB0696 Retention rates of adalimumab, etanercept, and infliximab as first- or second-line biotherapies for spondyloarthritis patients in daily practice in auvergne (france)